Most people start GLP-1 therapy on a deliberately low dose, feel mild nausea in the first few weeks, and notice appetite genuinely quieting by weeks four to eight. Meaningful weight loss builds over months, not days, with the largest trial losses landing around 68 to 72 weeks of continuous treatment.
How does GLP-1 therapy actually start?
You do not begin at an effective dose. Every approved GLP-1 drug uses titration: a low starting dose that steps up every four weeks or so. Semaglutide for weight management typically starts at 0.25 mg weekly, and tirzepatide at 2.5 mg, both far below the doses that drive the headline results. The point of the low start is tolerance, not effect. Climbing too fast is the most common reason people feel miserable and quit. Our guide on when to increase a GLP-1 dose covers how to judge readiness for each step.
What happens in the first week?
The first injection is usually uneventful. Many people feel nothing dramatic for a few days, then notice meals feel "smaller" sooner. Mild nausea, a little reflux, or early fullness are the typical first signals that the drug is working. Weight on the scale may not move at all in week one, and that is normal. What you are looking for early is a quieter relationship with food, not a number.
When do side effects show up and fade?
Gastrointestinal side effects are the rule, not the exception, and they cluster around each dose increase. Nausea, constipation, and occasional diarrhea tend to spike for a few days after stepping up, then settle as your body adapts. For most people the worst window is the first one to two months of titration.
| Timeframe | What is common |
|---|---|
| Week 1-2 | Mild nausea, early fullness, possible reflux |
| Week 3-4 | First dose increase, symptoms briefly return |
| Month 2-3 | Symptoms ease for most as the body adapts |
| Month 4+ | Usually mild and intermittent at maintenance |
Practical management, smaller meals, lower fat, hydration, is covered in our piece on why GLP-1 nausea happens and what helps.
When does appetite actually quiet down?
The shift many people describe as losing "food noise," the constant mental chatter about eating, usually becomes obvious somewhere between weeks four and eight, as you reach the first meaningfully effective doses. Cravings soften, portions shrink without much willpower, and you may forget to snack. This is the mechanism doing its job, and our explainer on what GLP-1 food noise means describes the experience in more detail.
What does month-by-month weight loss look like?
Trial data give a realistic pace. In the STEP 1 trial, semaglutide produced about 14.9% average loss by week 68; in SURMOUNT-1, tirzepatide reached roughly 22.5% by week 72. The curve is gradual and roughly steady, not front-loaded.
| Timepoint | Typical cumulative loss (approx) |
|---|---|
| Month 1 | 1-3% |
| Month 3 | 5-8% |
| Month 6 | 10-15% |
| Month 12+ | 15-22%+ depending on drug and dose |
Your own pace depends on the drug, your top dose, and how consistently you hit protein and activity targets. The month-by-month view in GLP-1 before and after shows how individual timelines vary around these averages.
What is normal versus a red flag?
Normal: mild to moderate nausea, constipation, fatigue, reduced appetite, and slow steady weight loss. Worth a call to your prescriber: severe or persistent vomiting, signs of dehydration, severe abdominal pain that radiates to the back (a possible pancreatitis signal), or symptoms of gallbladder trouble. Feeling no appetite at all to the point of skipping protein and fluids is also a problem worth flagging rather than pushing through.
A useful rule of thumb is that intensity and duration separate normal from concerning. Nausea that follows a dose increase and eases within a few days is expected; nausea severe enough to stop you keeping fluids down is not. Mild fatigue as your calorie intake drops is common; sudden dizziness on standing can signal dehydration or low blood sugar and deserves attention. Most people never hit a red flag, but knowing the difference keeps you from either quitting over something routine or ignoring something that matters.
What happens when weight loss stalls?
Plateaus are expected, not failures. Weight often pauses for several weeks, especially between dose increases or as you approach your top dose. Most plateaus resolve with a dose step-up, tighter protein intake, resistance training, or simply more time. Our guide on why a GLP-1 plateau happens walks through the usual causes and fixes before anyone considers changing drugs.
What should you eat and do to make it easier?
Three habits make the experience smoother: prioritize protein (roughly 1.2-1.6 g per kg of target body weight) to protect muscle, eat smaller portions slowly to limit nausea, and stay hydrated because reduced intake can leave you short on fluids and electrolytes. Resistance training matters too, since rapid loss can take lean mass along with fat. These habits also set up the maintenance phase, covered in what the GLP-1 maintenance phase involves.
It also helps to reset expectations about what "success" looks like week to week. Because the drug works by reducing appetite rather than forcing rapid loss, the most reliable early sign of progress is behavioral, eating less without effort, rather than a fast-dropping scale. People who track only weight tend to feel discouraged during normal flat stretches, while those who also notice smaller portions, fewer cravings, and better lab markers stay the course. Treating the first few months as a build phase, where you establish protein, hydration, and training habits at low doses, pays off later when you reach the doses that drive most of the weight loss.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
- U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf
Frequently Asked Questions
How long until GLP-1 therapy starts working?
Appetite suppression often appears within the first few weeks, but visible weight loss builds over months. Most trial participants needed a year or more on an effective dose to reach their full result.
Is nausea a sign the dose is too high?
Mild nausea after a dose increase is expected and usually fades within days. Severe or persistent vomiting is different and should prompt a slower titration or a call to your prescriber.
Do you have to stay on it forever?
GLP-1 therapy treats obesity as a chronic condition, and weight regain is common after stopping. Many people transition to a maintenance dose rather than discontinuing entirely.
What if the scale stops moving?
Plateaus are normal, especially between dose increases. They usually break with a higher dose, more protein, resistance training, or more time before any drug change is considered.
This article is educational and not medical advice; treatment decisions should be made with a licensed clinician.
